Content Directory » Points of Discussion – Academic Versus Private Clinical Trials

Points of Discussion – Academic Versus Private Clinical Trials

Educational Programs
2026

This three‑part podcast series offers a clear, engaging look inside the world of clinical trials—from how they begin, to where they happen, to how collaboration across sectors drives innovation in patient care. Through conversations with expert investigators, listeners gain a behind‑the‑scenes understanding about the complementary roles of academic centers and private practice sites, and the real‑world challenges and opportunities that shape modern research.

Academic Clinical Trials: How They Work

Private Practice Trials: Speed and Access

Academic + Industry: Collaboration is Key

Support for this independent medical education program comes from Incyte.

Thy Huynh, MD
Pediatric Dermatologist
Program Host

Dr. Huynh is a board certified pediatric dermatologist. She is an Assistant Professor in Dermatology and Pediatrics at the University of Mississippi Medical Center and the Director of Clinical Trials in Dermatology.

Dr. Huynh has no disclosures relevant to this discussion.


Jason Hawkes, MD, MS
Dermatologist
Program Guest

Dr. Hawkes is a board certified dermatologist and the Co-Owner and Chief Scientific Officer and Investigator at the Oregon Medical Research Center in Portland, Oregon.

Dr. Hawkes has the following disclosures:
Advisor/Consultant
AbbVie, Alumis, Apogee, Arcutis, Boehringer Ingelheim, Blueprint Medicines, BMS, Dermavant, Eli Lilly, Galderma, Incyte, Janssen, Kymera Therapeutics, LEO, Novartis, Oruka, Regeneron, Sanofi, Sun Pharma, Takeda, and UCB
Speaker
Alumis, BMS, Boehringer Ingelheim, Dermavant, Eli Lilly, Galderma, Janssen, Novartis, Regeneron, Sanofi, and UCB
Investigator
AbbVie, Acelyrin, Allakos, Alumis, Amgen, Apogee, BMS, Celldex, Concert Pharmaceuticals, Eli Lilly, Incyte, Janssen, Kymera Therapeutics, LEO, Navigator Medicines, Novartis, Oruka, Pfizer, Priovant Therapeutics, Sanofi, Sun Pharma, Takeda, and UCB
Other
American Academy of Dermatology (AAD) Delegate for International Guidelines for Urticaria Workgroup
Deputy Chair of Council on Education, American Academy of Dermatology (AAD)
Scientific Advisory Committee, National Psoriasis Foundation (NPF)
Councilor, International Psoriasis Council (IPC)

Jeff Sugarman, MD, PhD
Pediatric Dermatologist
Program Guest

Dr. Sugarman is a board certified pediatric dermatologist and founding member of PeDRA. Dr. Sugarman is the Medical Director at Redwood Family Dermatology, and a Volunteer Clinical Professor at the University of California, San Francisco Department of Dermatology and Family Medicine.

Dr. Sugarman is no longer a principal investigator, but does consult for companies to assist with protocol development and review, and to provide safety monitoring.


WordPress Ads